The Society for Immunotherapy of Cancer (SITC) hosted Session 106c during the 38th Annual Meeting & Pre-Conference Programs on Friday, November 3, 2023. Available here are the presentation slides and video from “Session 106c: Immunoprevention of Cancer” as permitted by presenters.
Philip Castle, MD, MPH – National Cancer Institute
Catherine Wu, MD – Dana-Farber Cancer Institute
Given the evidence that prevention and screening have the greatest impact on reducing mortality due to cancer in the population, this session will cover a wide range of topics related to the emerging, exciting field of immunoprevention. Topics will include: 1) immunobiology and its role in carcinogenesis; 2) primary and secondary prevention, including identifying and intercepting pre-neoplastic conditions and targeting of breast cancer; 3) targeting high-risk populations such as those with hereditary cancer syndromes; 4) repurposing technologies and interventions for immunoprevention, such as mRNA vaccines and immunotherapy, respectively; and 5) pragmatic considerations for developing immunoprevention strategies, including NCI programs and clinical trial designs and endpoints.
To view the entire program schedule (including presenter permission to post) please click here.
SITC 2023 Annual Meeting: Friday, November 301:42:17